002038 双鹭药业
已收盘 05-09 15:00:00
资讯
新帖
简况
双鹭药业(002038)2025年一季报简析:净利润减34.46%,三费占比上升明显
证券之星 · 04-22
双鹭药业(002038)2025年一季报简析:净利润减34.46%,三费占比上升明显
图解双鹭药业一季报:第一季度单季净利润同比减34.46%
证券之星 · 04-21
图解双鹭药业一季报:第一季度单季净利润同比减34.46%
双鹭药业(002038.SZ)发布一季度业绩,归母净利润4596.84万元,同比下降34.46%
智通财经 · 04-21
双鹭药业(002038.SZ)发布一季度业绩,归母净利润4596.84万元,同比下降34.46%
双鹭药业收盘上涨1.02%,滚动市盈率86.04倍,总市值70.89亿元
金融界 · 03-10
双鹭药业收盘上涨1.02%,滚动市盈率86.04倍,总市值70.89亿元
双鹭药业:目前公司获得的信息没有与Deepseek合作或者产品接入Deepseek大模型的信息
证券之星 · 02-14
双鹭药业:目前公司获得的信息没有与Deepseek合作或者产品接入Deepseek大模型的信息
双鹭药业最新公告:2024年预亏3200万元-5200万元 同比盈转亏
证券之星 · 01-24
双鹭药业最新公告:2024年预亏3200万元-5200万元 同比盈转亏
【抗流感概念震荡拉升 鲁抗医药、罗欣药业双双涨停】鲁抗医药、罗欣药业涨停,亨迪药业、新华制药、奥翔药业、双鹭药业等跟涨。消息面上,1月2日,叮当快药发布数据,呼吸道疾病用药销量持续走高。近一个月内,抗流感药品奥司他韦及速福达,销售增长率高达164%。同时,感冒发热类产品销量均增长显著,以常用的退热贴为例,销售增长率为181.5%。
金融界 · 01-03
【抗流感概念震荡拉升 鲁抗医药、罗欣药业双双涨停】鲁抗医药、罗欣药业涨停,亨迪药业、新华制药、奥翔药业、双鹭药业等跟涨。消息面上,1月2日,叮当快药发布数据,呼吸道疾病用药销量持续走高。近一个月内,抗流感药品奥司他韦及速福达,销售增长率高达164%。同时,感冒发热类产品销量均增长显著,以常用的退热贴为例,销售增长率为181.5%。
【化学制药板块异动拉升,亨迪药业涨超12%】化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6%。
金融界 · 01-03
【化学制药板块异动拉升,亨迪药业涨超12%】化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6%。
A股化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6
美港电讯 · 01-03
A股化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6
双鹭药业(002038)12月31日主力资金净卖出5250.17万元
证券之星 · 01-02
双鹭药业(002038)12月31日主力资金净卖出5250.17万元
12月23日双鹭药业涨停分析:肝素,减肥药,基因编辑概念热股
证券之星 · 2024-12-23
12月23日双鹭药业涨停分析:肝素,减肥药,基因编辑概念热股
A股化学制药概念局部异动,小方制药、双鹭药业涨停,亨迪药业涨超10%,鲁抗医药、拓新药业、新和成等跟涨。
美港电讯 · 2024-12-23
A股化学制药概念局部异动,小方制药、双鹭药业涨停,亨迪药业涨超10%,鲁抗医药、拓新药业、新和成等跟涨。
异动快报:双鹭药业(002038)12月23日10点2分触及涨停板
证券之星 · 2024-12-23
异动快报:双鹭药业(002038)12月23日10点2分触及涨停板
又一家“A转港”,“长风药业”专注吸入制剂,2023年扭亏为盈
活报告 · 2024-11-29
又一家“A转港”,“长风药业”专注吸入制剂,2023年扭亏为盈
双鹭药业:地氯雷他定片获药品注册证书
美港电讯 · 2024-11-21
双鹭药业:地氯雷他定片获药品注册证书
双鹭药业:关于董事辞职及补选第九届董事会非独立董事的公告
新浪财经-鹰眼工作室 · 2024-11-21
双鹭药业:关于董事辞职及补选第九届董事会非独立董事的公告
双鹭药业最新公告:获得地氯雷他定片药品注册证书
证券之星 · 2024-11-21
双鹭药业最新公告:获得地氯雷他定片药品注册证书
双鹭药业(002038.SZ)获得地氯雷他定片药品注册证书
智通财经 · 2024-11-21
双鹭药业(002038.SZ)获得地氯雷他定片药品注册证书
双鹭药业(002038.SZ)发布前三季度业绩,净亏损1673.56万元
智通财经 · 2024-10-25
双鹭药业(002038.SZ)发布前三季度业绩,净亏损1673.56万元
双鹭药业(002038.SZ)董事兼董事会秘书梁淑洁减持50万股
智通财经 · 2024-10-16
双鹭药业(002038.SZ)董事兼董事会秘书梁淑洁减持50万股
加载更多
公司概况
公司名称:
北京双鹭药业股份有限公司
所属行业:
医药制造业
上市日期:
2004-09-09
主营业务:
北京双鹭药业股份有限公司的主营业务是基因工程及相关药物的研究开发和生产经营。公司的主要产品是生物、生化药、化学药。近几年公司获得国内授权专利十余项,获得PCT国际专利三项,申请国内外专利五十余项。
发行价格:
12.00
{"stockData":{"symbol":"002038","market":"SZ","secType":"STK","nameCN":"双鹭药业","latestPrice":6.59,"timestamp":1746774231000,"preClose":6.6,"halted":0,"volume":6298050,"delay":0,"changeRate":-0.0015,"floatShares":852000000,"shares":1027000000,"eps":-0.0957,"marketStatus":"已收盘","change":-0.01,"latestTime":"05-09 15:00:00","open":6.58,"high":6.63,"low":6.55,"amount":41514200,"amplitude":0.0121,"askPrice":6.59,"askSize":293,"bidPrice":6.58,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-0.0957,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.6,"symbolType":"stock","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":7.26,"lowLimit":5.94,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1027350000,"isCdr":false,"pbRate":1.21,"roa":"--","roe":"0.82%","epsLYR":-0.07,"committee":-0.52746,"marketValue":6770000000,"turnoverRate":0.0074,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-05-12。","floatMarketCap":5612000000},"requestUrl":"/m/hq/s/002038","defaultTab":"news","newsList":[{"id":"2529569698","title":"双鹭药业(002038)2025年一季报简析:净利润减34.46%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2529569698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529569698?lang=zh_cn&edition=full","pubTime":"2025-04-23 06:14","pubTimestamp":1745360083,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期双鹭药业发布2025年一季报。截至本报告期末,公司营业总收入1.69亿元,同比下降31.1%,归母净利润4596.84万元,同比下降34.46%。本报告期双鹭药业三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达70.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042300005839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002038"],"gpt_icon":0},{"id":"2529336851","title":"图解双鹭药业一季报:第一季度单季净利润同比减34.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529336851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529336851?lang=zh_cn&edition=full","pubTime":"2025-04-22 01:40","pubTimestamp":1745257202,"startTime":"0","endTime":"0","summary":"证券之星消息,双鹭药业2025年一季报显示,公司主营收入1.69亿元,同比下降31.1%;归母净利润4596.84万元,同比下降34.46%;扣非净利润2114.18万元,同比下降79.19%;负债率7.23%,投资收益559.19万元,财务费用-127.69万元,毛利率59.27%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042200001685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002038"],"gpt_icon":0},{"id":"2529382273","title":"双鹭药业(002038.SZ)发布一季度业绩,归母净利润4596.84万元,同比下降34.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529382273","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529382273?lang=zh_cn&edition=full","pubTime":"2025-04-22 00:08","pubTimestamp":1745251682,"startTime":"0","endTime":"0","summary":"智通财经APP讯,双鹭药业(002038.SZ)发布2025年一季度报告,第一季度,公司实现营业收入1.69亿元,同比下降31.10%。归属于上市公司股东的净利润4596.84万元,同比下降34.46%。归属于上市公司股东的扣除非经常性损益的净利润2114.18万元,同比下降79.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002038"],"gpt_icon":0},{"id":"2518507218","title":"双鹭药业收盘上涨1.02%,滚动市盈率86.04倍,总市值70.89亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518507218","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518507218?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:26","pubTimestamp":1741595198,"startTime":"0","endTime":"0","summary":"3月10日,双鹭药业今日收盘6.9元,上涨1.02%,滚动市盈率PE达到86.04倍,总市值70.89亿元。从行业市盈率排名来看,公司所处的生物制品行业市盈率平均41.57倍,行业中值37.39倍,双鹭药业排名第66位。股东方面,截至2024年9月30日,双鹭药业股东户数61868户,较上次减少1924户,户均持股市值35.28万元,户均持股数量2.76万股。北京双鹭药业股份有限公司主要专注于基因工程及相关药物的研究开发和生产经营,紧紧围绕疾病谱的变化布局研发和生产。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10162648625643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","BK0028","002038","BK0239"],"gpt_icon":0},{"id":"2511657180","title":"双鹭药业:目前公司获得的信息没有与Deepseek合作或者产品接入Deepseek大模型的信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2511657180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511657180?lang=zh_cn&edition=full","pubTime":"2025-02-14 17:30","pubTimestamp":1739525425,"startTime":"0","endTime":"0","summary":"请问贵公司控股的嘉兴颐和股权投资基金合伙企业12个投资项目中公司中有跟Deepseek合作或者产品接入Deepseek大模型的吗?双鹭药业董秘:您好, 公司会在定期报告中披露股东人数变化,截至2024年9月30日,公司股东总户数为61,868。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021400028140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002038"],"gpt_icon":0},{"id":"2505486467","title":"双鹭药业最新公告:2024年预亏3200万元-5200万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2505486467","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505486467?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:19","pubTimestamp":1737731997,"startTime":"0","endTime":"0","summary":"双鹭药业公告,预计归属于上市公司股东的净利润亏损3,200万元-5,200万元,同比盈转亏。主要系报告期内公司产品价格下降导致营业收入降低,同时持有交易性金融资产产生的股价变动较大,导致净利润减少金额1.78亿元。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025012400057259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0028","002038"],"gpt_icon":0},{"id":"2500513307","title":"【抗流感概念震荡拉升 鲁抗医药、罗欣药业双双涨停】鲁抗医药、罗欣药业涨停,亨迪药业、新华制药、奥翔药业、双鹭药业等跟涨。消息面上,1月2日,叮当快药发布数据,呼吸道疾病用药销量持续走高。近一个月内,抗流感药品奥司他韦及速福达,销售增长率高达164%。同时,感冒发热类产品销量均增长显著,以常用的退热贴为例,销售增长率为181.5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500513307","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500513307?lang=zh_cn&edition=full","pubTime":"2025-01-03 09:52","pubTimestamp":1735869156,"startTime":"0","endTime":"0","summary":"鲁抗医药、罗欣药业涨停,亨迪药业、新华制药、奥翔药业、双鹭药业等跟涨。消息面上,1月2日,叮当快药发布数据,呼吸道疾病用药销量持续走高。近一个月内,抗流感药品奥司他韦及速福达,销售增长率高达164%。同时,感冒发热类产品销量均增长显著,以常用的退热贴为例,销售增长率为181.5%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/03095247073919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0188","002793","BK0239","000756","09886","BK1142","BK0132","BK0028","BK0201","301211","BK0046","BK1247","BK0001","603229","BK0164","BK0168","08058","600789","002038"],"gpt_icon":0},{"id":"2500133768","title":"【化学制药板块异动拉升,亨迪药业涨超12%】化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500133768","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500133768?lang=zh_cn&edition=full","pubTime":"2025-01-03 09:52","pubTimestamp":1735869148,"startTime":"0","endTime":"0","summary":"化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/03095247073903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0028","BK0001","BK1191","BK0191","BK0201","002038","000756","000952","301211","BK0239","002793","01477","BK0132","BK0164","08058","BK0188","BK1574"],"gpt_icon":0},{"id":"2500133106","title":"A股化学制药板块异动拉升,亨迪药业涨超12%,罗欣药业、鲁抗药业、新华制药、广济药业均封板涨停,新赣江、双鹭药业等涨超6","url":"https://stock-news.laohu8.com/highlight/detail?id=2500133106","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500133106?lang=zh_cn&edition=full","pubTime":"2025-01-03 09:48","pubTimestamp":1735868928,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["000952","BK0191","002038","159982","BK0132","BK0188","BK0028","002793","01477","399300","000756","301211","BK0201","BK1574","08058","BK0164","BK1191","BK0001","BK0239"],"gpt_icon":0},{"id":"2500965484","title":"双鹭药业(002038)12月31日主力资金净卖出5250.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500965484","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500965484?lang=zh_cn&edition=full","pubTime":"2025-01-02 09:20","pubTimestamp":1735780855,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年12月31日收盘,双鹭药业报收于7.47元,下跌6.86%,换手率5.84%,成交量49.72万手,成交额3.83亿元。近5日资金流向一览见下表:双鹭药业融资融券信息显示,融资方面,当日融资买入4250.9万元,融资偿还3920.54万元,融资净买入330.36万元,连续3日净买入累计1588.97万元。双鹭药业主营业务:专注于基因工程及相关药物的研究开发和生产经营,紧紧围绕疾病谱的变化布局研发、生产和服务领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010200003005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002038","BK0188","BK0028","BK0239"],"gpt_icon":0},{"id":"2493784694","title":"12月23日双鹭药业涨停分析:肝素,减肥药,基因编辑概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493784694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493784694?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:18","pubTimestamp":1734938302,"startTime":"0","endTime":"0","summary":"证券之星消息,双鹭药业12月23日涨停收盘,收盘价7.98元。该股于9点46分涨停,4次打开涨停,截止收盘封单资金为2653.95万元,占其流通市值0.39%。12月23日的资金流向数据方面,主力资金净流入1.07亿元,占总成交额15.56%,游资资金净流出3720.69万元,占总成交额5.41%,散户资金净流出6985.84万元,占总成交额10.15%。近5日资金流向一览见下表:该股为肝素,减肥药,基因编辑概念热股。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300014109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002038","BK0239","BK0028","BK0188"],"gpt_icon":0},{"id":"2493208202","title":"A股化学制药概念局部异动,小方制药、双鹭药业涨停,亨迪药业涨超10%,鲁抗医药、拓新药业、新和成等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2493208202","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493208202?lang=zh_cn&edition=full","pubTime":"2024-12-23 10:28","pubTimestamp":1734920933,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0187","301089","BK1191","002001","LU0405327148.USD","LU0405327494.USD","399300","BK1574","BK0168","01477","BK0070","301211","BK0197","BK0239","600789","BK0046","002038","BK0188","159982","603207","BK0028","BK0191"],"gpt_icon":0},{"id":"2493720854","title":"异动快报:双鹭药业(002038)12月23日10点2分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2493720854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493720854?lang=zh_cn&edition=full","pubTime":"2024-12-23 10:05","pubTimestamp":1734919532,"startTime":"0","endTime":"0","summary":"证券之星12月23日盘中消息,10点2分双鹭药业(002038)触及涨停板。目前价格7.98,上涨10.07%。其所属行业化学制药目前下跌。领涨股为双鹭药业。该股为疫苗,基因编辑,长寿药NMN概念热股。12月20日的资金流向数据方面,主力资金净流入34.15万元,占总成交额0.49%,游资资金净流入434.78万元,占总成交额6.26%,散户资金净流出468.94万元,占总成交额6.76%。近5日资金流向一览见下表:双鹭药业主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300004968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002038","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2487532810","title":"又一家“A转港”,“长风药业”专注吸入制剂,2023年扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2487532810","media":"活报告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487532810?lang=zh_cn&edition=full","pubTime":"2024-11-29 18:45","pubTimestamp":1732877100,"startTime":"0","endTime":"0","summary":"LiveReport获悉,来自江苏苏州的长风药业股份有限公司于2024年11月28日在港交所递交上市申请,拟香港主板上市,这是该公司第1次递交上市申请,联席保荐人为中信证券和招银国际。行业前景全球及中国吸入制剂市场规模全球吸入制剂市场预计将由2023年的290亿美元增长到2033年的454亿美元,2023年至2033年的年复合增长率为4.6%。预计中国市场同期的增长更快,将由人民币252亿元增至人民币443亿元,2023年至2033年的年复合增长率为5.8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/cj/2024-11-29/doc-incxtqvq8687004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600380","LU1829250122.USD","LU0889565916.HKD","AZN","LU0109394709.USD","BK0077","LU0320765992.SGD","LU2462157665.USD","BK0028","BK4568","LU2417539215.USD","BK0114","002038","BK0188","BK0239","BK4585","LU2456880835.USD","BK4007","LU2236285917.USD","BK4588","BK0046"],"gpt_icon":0},{"id":"2485464904","title":"双鹭药业:地氯雷他定片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485464904","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485464904?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:46","pubTimestamp":1732189571,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002038","BK0239","BK0028","BK0188"],"gpt_icon":0},{"id":"2485464703","title":"双鹭药业:关于董事辞职及补选第九届董事会非独立董事的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2485464703","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485464703?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:20","pubTimestamp":1732188000,"startTime":"0","endTime":"0","summary":"北京双鹭药业股份有限公司关于董事辞职及补选第九届董事会非独立董事的公告本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、误导性陈述或重大遗漏。此次补选后,公司董事会中兼任公司高级管理人员以及由职工代表担任的董事人数总计不超过公司董事总数的二分之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-21/doc-incwvpzh4564361.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0188","002038","BK0239"],"gpt_icon":0},{"id":"2485777469","title":"双鹭药业最新公告:获得地氯雷他定片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485777469","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485777469?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:10","pubTimestamp":1732187446,"startTime":"0","endTime":"0","summary":"双鹭药业公告,公司近日收到国家药监局核准签发的地氯雷他定片(5mg,商品名:新雷宁®)《药品注册证书》。地氯雷他定片为口服第三代非镇静性长效三环类抗组胺药,主要用于缓解慢性特发性荨麻疹及过敏性鼻炎的相关症状。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112100030731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","002038","BK0239"],"gpt_icon":0},{"id":"2485466710","title":"双鹭药业(002038.SZ)获得地氯雷他定片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485466710","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485466710?lang=zh_cn&edition=full","pubTime":"2024-11-21 19:01","pubTimestamp":1732186917,"startTime":"0","endTime":"0","summary":"智通财经APP讯,双鹭药业(002038.SZ)公告,公司于近日收到国家药品监督管理局(简称“国家药监局”)核准签发的地氯雷他定片(5mg,商品名:新雷宁®)《药品注册证书》。据悉,地氯雷他定片为口服第三代非镇静性长效三环类抗组胺药,是氯雷他定主要活性代谢产物,对外周组胺H1受体的亲和力和选择性更高,不经肝脏代谢直接起效,半衰期长达17-24h,起效速度更快,作用更持久。无抗胆碱和中枢抑制作用,无心脏毒性,与其他药物以及食物间的相互作用更少。主要用于缓解慢性特发性荨麻疹及过敏性鼻炎的相关症状。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","002038","BK0028","BK0239"],"gpt_icon":0},{"id":"2478983682","title":"双鹭药业(002038.SZ)发布前三季度业绩,净亏损1673.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478983682","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478983682?lang=zh_cn&edition=full","pubTime":"2024-10-25 19:20","pubTimestamp":1729855249,"startTime":"0","endTime":"0","summary":"智通财经APP讯,双鹭药业(002038.SZ)发布2024年三季度报告,前三季度,公司实现营业收入5.41亿元,同比下降30.40%。归属于上市公司股东净亏损1673.56万元。归属于上市公司股东的扣除非经常性损益的净利润7799.07万元,同比下降61.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1200116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002038","BK0028","BK0188"],"gpt_icon":0},{"id":"2475982789","title":"双鹭药业(002038.SZ)董事兼董事会秘书梁淑洁减持50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475982789","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475982789?lang=zh_cn&edition=full","pubTime":"2024-10-16 20:20","pubTimestamp":1729081213,"startTime":"0","endTime":"0","summary":"智通财经APP讯,双鹭药业(002038.SZ)公告,公司董事兼董事会秘书梁淑洁于2024年7月16日-2024年10月15日累计减持公司股份50万股,占公司总股本的比例0.0487%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0239","BK0028","002038"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746895576444,"stockEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0494},{"period":"3month","weight":-0.0545},{"period":"6month","weight":-0.1272},{"period":"1year","weight":-0.2493},{"period":"ytd","weight":-0.1178}],"compareEarnings":[{"period":"1week","weight":0.0192},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0595},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京双鹭药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"176098人(较上一季度增加205.26%)","perCapita":"4835股","listingDate":"2004-09-09","address":"北京市海淀区阜石路69号碧桐园1号楼4层","registeredCapital":"102735万元","survey":" 北京双鹭药业股份有限公司的主营业务是基因工程及相关药物的研究开发和生产经营。公司的主要产品是生物、生化药、化学药。近几年公司获得国内授权专利十余项,获得PCT国际专利三项,申请国内外专利五十余项。","listedPrice":12},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"双鹭药业(002038)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供双鹭药业(002038)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"双鹭药业,002038,双鹭药业股票,双鹭药业股票老虎,双鹭药业股票老虎国际,双鹭药业行情,双鹭药业股票行情,双鹭药业股价,双鹭药业股市,双鹭药业股票价格,双鹭药业股票交易,双鹭药业股票购买,双鹭药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"双鹭药业(002038)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供双鹭药业(002038)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}